MECP2 and Rett syndrome: To clarify this doubt, in 2016, Ross et al. investigated the peripheral contribution of Mecp2 deficiency to the most significant clinical features of RTT, generating a mouse model in which Mecp2 is reactivated almost to physiological levels in the brain but remains silenced in other tissues [71].